Assessment of Metformin as an Additional Treatment to Therapeutic Lifestyle Changes in Pediatric Patients with Metabolic Syndrome

Table 2

𝑃 values comparing the difference between the M group and the C group at the initial data collection and at the final data collection.

	Initial 𝑃 value	Final 𝑃 value
LDL (mg/dL)	0.86	0.62
LDL (percentile)	0.69	0.30
HDL (mg/dL)	0.68	0.46
HDL (percentile)	0.76	0.78
TG (mg/dL)	0.81	0.95
TG (percentile)	0.51	0.98
ALT (U/L)	0.31	0.16
AST (U/L)	0.26	0.14
Weight (kg)	0.16	0.63
Weight (percentile)	0.21	0.59
Weight (z-score)	0.08	0.22
Height (cm)	0.17	0.26
Height (percentile)	0.046^*	0.02^*
Height (z-score)	0.04^*	0.03^*
Insulin (𝜇U/mL)	0.15	0.30
Glucose (mg/dL)	0.07	0.85
BP-systolic (mmHg)	0.01^*	0.83
BP-diastolic (mmHg)	0.48	0.19
BP-systolic (percentile)	0.13	0.36
BP-diastolic (percentile)	0.08	0.40
Waist (in.)	0.14	0.24
Waist (percentile)	1.00	0.73
Body fat (%)	0.73	0.72
BMI (kg/m^2)	0.29	0.36
BMI (percentile)	0.80	0.51
BMI (z-score)	0.42	0.85

^*Reaches statistical significance (𝑃 value <0.05).